Resistance of Cancer Cells to CTL-Mediated Immunotherapy

Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Medical Science, Pharmacology
Cover of the book Resistance of Cancer Cells to CTL-Mediated Immunotherapy by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319178073
Publisher: Springer International Publishing Publication: June 20, 2015
Imprint: Springer Language: English
Author:
ISBN: 9783319178073
Publisher: Springer International Publishing
Publication: June 20, 2015
Imprint: Springer
Language: English

This comprehensive volume explores the latest research on the mechanisms of resistance in cancer cells to CTL-mediated immunotherapy. Chapter topics discuss cell-mediated immunity as the result of cytotoxic T-lymphocytes (CTL) directed specifically against cancer cells. In addition, the volume reviews how CTL mediate the cytotoxic activity, in large part, by the indication of apoptosis; hence, tumor cells develop anti-apoptotic mechanisms and thereby, resist CTL-induced apoptosis. In order for CTL-mediated antitumor immunotherapy to be effective, it is essential that agents directed against the resistant tumor cells sensitized cancer cells for CTL-mediated apoptosis. Examples of such agents discussed in the volume include are HDAC inhibitors, proteasome inhibitors, Bcl-2 family inhibitors, PARP, antibodies, and more.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This comprehensive volume explores the latest research on the mechanisms of resistance in cancer cells to CTL-mediated immunotherapy. Chapter topics discuss cell-mediated immunity as the result of cytotoxic T-lymphocytes (CTL) directed specifically against cancer cells. In addition, the volume reviews how CTL mediate the cytotoxic activity, in large part, by the indication of apoptosis; hence, tumor cells develop anti-apoptotic mechanisms and thereby, resist CTL-induced apoptosis. In order for CTL-mediated antitumor immunotherapy to be effective, it is essential that agents directed against the resistant tumor cells sensitized cancer cells for CTL-mediated apoptosis. Examples of such agents discussed in the volume include are HDAC inhibitors, proteasome inhibitors, Bcl-2 family inhibitors, PARP, antibodies, and more.

More books from Springer International Publishing

Cover of the book Chemistry Beyond Chlorine by
Cover of the book Value Networks in Manufacturing by
Cover of the book Climate Change, Extreme Events and Disaster Risk Reduction by
Cover of the book Imaging Biomarkers by
Cover of the book Multiagent System Technologies by
Cover of the book To Mars and Beyond, Fast! by
Cover of the book Fundamentals of Tensor Calculus for Engineers with a Primer on Smooth Manifolds by
Cover of the book Trustworthy Global Computing by
Cover of the book Proceedings of 3rd International Sustainable Buildings Symposium (ISBS 2017) by
Cover of the book High Performance Soft Magnetic Materials by
Cover of the book Meanings & Co. by
Cover of the book Plant ABC Transporters by
Cover of the book Accurate and Robust Spectral Testing with Relaxed Instrumentation Requirements by
Cover of the book Bioinformatics Research and Applications by
Cover of the book Chemistry of Polymeric Metal Chelates by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy